2025年国家留学基金管理委员会(CSC)奖学金录取结果近日公布。仁医医疗今年共协助35位医生提交申请,其中31人成功获得国家公派出国留学资格,平均每人将获得约36万元人民币奖学金。尽管仍有4位医生因各种原因未能通过评审,但他们的努力同样值得尊重,我们也将继续陪伴他们,明年再战。回顾过去几年的数据:2022年申请10人,全部获批;2023年申请18人,通过16人;2024年申请26人,通过22人;而2025年,申请人数首次突破30人,创下了31人通过的新高。这些获得CSC资助的医生将赴德国多所知名高校,跟随德国国家科学院院士、欧洲重要医学学会主席以及各专业领域的学科带头人攻读临床医学MD博士,录取院校包括海德堡大学、柏林夏洛特医科大学、亚琛工业大学、慕尼黑大学、哥廷根大学、慕尼黑工业大学、吉森大学和基尔大学等。国家对医学与科技人才的持续投入,让我们看到中国医生在全球医学舞台上不断拓展的可能性。仁医医疗将一如既往地为优秀青年医生的职业发展提供支持与保障,助力更多医生迈出关键一步,见证他们走出去、成长起来,再带着新的视野和能力回到临床。中国真正优秀的医生应该成为中国社会一群有道德、有信仰、有理想、有能力的人。
The results of the 2025 China Scholarship Council (CSC) government-sponsored study abroad program have recently been announced. This year, Gloryren assisted a total of 35 doctors in CSC applications, with 31 successfully securing the national scholarship for overseas study. On average, each recipient will receive a scholarship of approximately 360,000 Chinese yuan. While four applicants failed to get the scholarship this time due to various reasons, their efforts are equally commendable, and we will continue supporting them for next year’s application. Looking back at Gloryren’s data from the past few years: in 2022, 10 applicants were all approved; in 2023, 16 out of 18 applications were approved; in 2024, 22 out of 26 applications were approved. In 2025, the number of applicants exceeded 30 for the first time, reaching a new high of 31 approvals. These doctors funded by CSC will pursue MD degrees at renowned universities in Germany, studying under members of the German National Academy of Sciences Leopoldina, presidents of major European scientific organizations, and key academic leaders in various specialties. Admitting universities include Heidelberg University, Charité - Universitätsmedizin Berlin, RWTH Aachen University, Ludwig Maximilian University of Munich, University of Göttingen, Technical University of Munich, University of Giessen, and Kiel University. The Chinese government’s sustained investment in medical and technological talents has demonstrated the expanding possibilities for Chinese doctors on the global medical stage. Gloryren will as always provide support and guarantees for the career development of outstanding young doctors, helping more doctors take this crucial step forward, witness their growth through studying abroad, and return to clinical practice with new perspectives and capabilities. China's truly outstanding doctors should embody ethics, faith, ideals, and professional competence—becoming a driving force for progress in society.